AnthonyEmmanuelMegaMD

Oncology • Providence, RI

Assistant Professor of Medicine, Brown University

Join to view full profile

Dr. Mega is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mega's full profile

Already have an account?

Office
164 Summit Avenue
Fain 3
Providence, RI 02906
Phone+1 401-793-2920

Fax+1 401-793-2859

Education & Training

Roger Williams Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1988 - 1992
Geisel School of Medicine at DartmouthClass of 1988

Certifications & Licensure

RI State Medical License 1995 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top MD Consumers Checkbook

Clinical Trials

Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer Start of enrollment: 2009 Feb 01
Completed
Not Applicable
Cabazitaxel and Radiation For Patients With Prostate Cancer Start of enrollment: 2013 Jan 01
Terminated
Phase 2
Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258 Start of enrollment: 2011 Oct 01
Completed
Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin Start of enrollment: 2014 Jul 01
Terminated
Phase 2
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis Start of enrollment: 2013 May 01
Unknown status
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes Start of enrollment: 2018 May 25
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

321 citations
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, ...
Thomas Powles, Tibor Csőszi, Mustafa Ozguroglu, Nobuaki Matsubara, Lajos Géczi
The Lancet. Oncology. 2021-07-01
19 citations
Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract
David Berz, Tina Rizack, Sherry Weitzen, Anthony Mega, Joseph Renzulli
Clinical Medicine Insights. Oncology. 2012-01-01
458 citations
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.
Andrea B. Apolo, Jeffrey R. Infante, Ani Sarkis Balmanoukian, Manish R. Patel, Ding Wang
Journal of Clinical Oncology. 2017-04-04

Journal Articles

The Association of Lymph Node Dissection with 30-Day Perioperative Morbidity Among Men Undergoing Minimally Invasive Radical Prostatectomy: Analysis of the National Su...
Anthony Mega, Joseph 2nd Renzulli, Gyan Pareek, Boris Gershman, Ali Amin, Dragan Golijanin, Nature

Professional Memberships

American Society of Clinical Oncology - ASCO
Member